Eyes on next steps of orelabrutinib for MS
–2Q rev／np +1%／3%; all eyes on cost savings
Weather short-term headwinds in 2Q24; eyes on 2H24E recovery
1H23E earnings preview： All eyes on the Galaxy
Impairment as always; eyes on Aion’s upmarket
2024叶黄素护眼选购白皮书—EYE护双眼，素速开始
China Technology–Global fabless／IDM 3Q23 wrap： PC／SP recovery, auto／ industrial mixed; Eye on Edge AI as new growth driver
Positive profit alert for FY22; eyeing for a good FY23E
Labor Market Gender Gaps in Türkiye: A Bird’s Eye View
Eyes on the recovery and risk-reward
公众号
小程序
社群
公众号小程序社群